Home > Articles > Certification

  • Print
  • + Share This
This chapter is from the book

This chapter is from the book

Key Concepts

This chapter discussed immunologic disorders. The nursing student should use these key concepts to answer questions as they relate to the care of this client. Remembering the pathophysiology of the disease process, the treatment, and the laboratory values will help you to be able to answer questions in the physiologic integrity portion of the NCLEX exam.

Key Terms

  • AIDS
  • Clinical categories
  • HAART (Highly Active Antiretroviral Therapy)
  • Helper T4 lymphocyte
  • Kaposi’s sarcoma
  • Nucleoside analog reverse transcriptase inhibitors
  • Opportunistic infection
  • Pneumocystis carinii pneumonia (PCP)
  • Polymerase chain (PCR)
  • Protease inhibitor
  • Retrovirus
  • Ribonucleotide reductase inhibitors
  • Standard precautions
  • Viral culture
  • Viral load
  • Wasting syndrome
  • Western Blot assay

Diagnostic Tests

The exam reviewer should be knowledgeable of the preparation and care of clients receiving exams to diagnose immunologic disorders. While reviewing these diagnostic exams, the exam reviewer should be alert for information that would be an important part of nursing care for these clients. The pertinent labs and exams are as follows:

  • Human Leukocyte Antigen (HLA)
  • Anti-DNA antibody testing
  • Erythrocyte Sedimentation Rate (ESR)
  • Serum complement levels
  • Western Blot assay
  • Oral mucosal transudate test
  • Urine HIV antibody test
  • Rapid HIV antibody test
  • Home testing kits
  • Viral Load
  • Viral culture
  • CD4/CD8 counts + T cell count
  • Lymphocyte counts (WBC)
  • P24 antigen assay
  • Quantitative RNA assay: polymerase chain reaction
  • Biopsies for cancers
  • Pap smears for cervical cancer
  • Urinalysis
  • Chest x-rays
  • Sputum of lung secretions
  • Cultures and cell smears for other opportunistic diseases

Pharmacological Agents Used in the Care of the Client with Immunologic Disorders

An integral part of care to clients with immunologic disorders is pharmacological intervention. These medications provide an improvement of the clients’ endocrine problems. The nursing exam reviewer needs to focus on the drugs in Table 12.2. Included in this table are the most common drugs used to treat immunologic disorders. These medications are not inclusive of all the agents used to treat HIV and immune disorders; therefore, you will want to keep a current pharmacology text handy for reference.

TABLE 12.2 Pharmacological Agents Used in the Treatment of Clients with Immunologic Disorders

Drug Name


Side Effects

Nursing Care

Nucleoside Analog Reverse Transcriptase Inhibitors

These drugs are used to treat viral infections such as cytomegalovirus, herpes simplex virus (HSV), and varicella-zoster. They inhibit reverse transcriptase.

Zidovudine (Retrovir, AZT) *Combivir is a combination drug containing AZT and 3TC

Drug crosses the blood-brain barrier, causing dizziness.

Assess for dizziness; check CBC, liver, and renal function; can cause bone marrow suppression.

Didanosine (ddI, Videx)

Could lead to peripheral neuropathies; food decreases absorption of the drug. Might suppress bone marrow.

Administer on an empty stomach; monitor hearing and vision as well as neuro-logical function. Can increase effects of allopurinol (Zyloprim), magnesium sulfate, aluminum antacids. Can cause GI symptoms, pancreatitis, stomatitis. Rash, myalgia, hypertension, palpitations, ear pain and photophobia.

Zalcitabine (ddC, HIVID)

Same as above plus avoid alcohol.

Same as above, plus assess liver function.

Lamivudine (Epivir, 3TC)

Same as above; plus can lead to pancreatitis.

Same as above, plus avoid fatty foods.

Stavudine (d4T, Zerit)

Same as above.

Same as above.

Abavir (Ziagen)

Flu-like symptoms might indicate hypersensitivity to the drug. Stop drug and inform doctor immediately.

Same as above, plus assess for flu-like symptoms.

Non-Nucleoside Analog Reverse Transcriptase Inhibitors

These drugs inhibit synthesis of the enzyme reverse transcriptase.

Nevirapine (Viramune)

May cause headaches and arthralgia.

Do not give with antacids because they decrease the effectiveness of the drug.

Efavirenz (Sustiva)

Drug crosses blood-brain barrier.

Drug can lead to head-aches and vivid dreams.

Same as above.

Delavirdine (Rescriptor)

Could cause headaches and hives.

Keep in cool location because heat deteriorates medication.

Protease Inhibitors

These drugs work to block the HIV protease enzyme and to prevent viral replication and release of viral particles.

Saquinavir (Invirase)

Take with a high-fat, high-calorie meal for maximum effect.

Teach the client to avoid the sun because the medication could cause sun sensitivity.

Indinavir (Crixivan)

Administer on an empty stomach. Teach the client that taking on an empty stomach increases absorption. Could cause hepatotoxi-city.

Ritonavir (Norvir)

Drug could cause diarrhea and increased blood glucose levels.

Administer with food. Monitor blood glucose levels.

Nelfinavir (Viracept)

Same as above.

Same as above.

Amprenavir (Agenerase)

Same as above.

Same as above.

Lopinavir (Kaletra, ABT-378/r)

Same as above.

Same as above; do not give to clients with allergies to sulfonamides.

Ribonucleotide Reductase Inhibitors

These drugs interfere with DNA synthesis and help to stop viral replication.

Hydroxyurea (Hydrea)

Monitor CBC because drug could suppress bone marrow function.

Teach the client to report extreme fatigue.

Entry Inhibitors

Prevents the virus from fusing with the inside of a cell.

Enfuvirtide (Fuzeon, T-20)

Local reactions at the injection site. GI upset and diarrhea.

Monitor the injection site for nodules, errythema, and purities at the injection site.

Drugs Used to Treat Pneumocystis Carinii Pneumonia (PCP)

Trimethoprim/ sulfamethoxazole (Apo-Sulfatrim, Bactrim, Cotrim, Septra), metronidazole (Flagyl)

Could lead to nausea, vomiting, hyponatremia, rashes, fever, leucopenia, thrombocytopenia, and liver problems. Taking Flagyl with alcohol causes extreme nausea.

Should be given either prophylactically to prevent PCP or to treat. Do not take Flagyl with alcohol.

Pentamidine isethionate (Pentacarinate, Pentam)

This drug is given prophylactically for clients with a CD4+ count less than 200 and those with PCP.

Usually given IV, IM, or may be given in an aerosol prepa-ration. Should be given with a bronchodilator to prevent bronchospasms.

Narcotics/Analgesics Examples: morphine sulfate, meperidine (Demerol), hydrocodone (Lortab)

These drugs are used to treat myalgia and pain associated with AIDS.

Monitor for respiratory depression and oversedation.

Anticonvulsants Examples: phenytoin (Dilantin), fosphenytoin (Cerebyx), phenobarbital

These drugs are used to treat seizure disorders related to neurological effects of AIDS.

Monitor CBC; monitor for respiratory depression; oversedation. Dilantin could lead to gingival hypertrophy. (See Chapter 11, “Care of the Client with Disorders of the Neurological System.”)

Drugs Used to Treat Fungal Infections Fluconazole (Diflucan) for cryptococcosis Ketoconazole (Nizoral) for histoplasmosis Nystatin (Monistat) for vaginal yeast infections * Unresolved vaginal yeast infections may indicate infections with HIV.

These drugs can cause nausea and vomiting.

Monitor CBC.

Drugs Used to Treat Tuberculosis Pyrazinamide (Tebrazid), isoniazid (Laniazid)

See Chapter 5, “Care of the Client with Respiratory Disorders.”

  • + Share This
  • 🔖 Save To Your Account

InformIT Promotional Mailings & Special Offers

I would like to receive exclusive offers and hear about products from InformIT and its family of brands. I can unsubscribe at any time.


Pearson Education, Inc., 221 River Street, Hoboken, New Jersey 07030, (Pearson) presents this site to provide information about products and services that can be purchased through this site.

This privacy notice provides an overview of our commitment to privacy and describes how we collect, protect, use and share personal information collected through this site. Please note that other Pearson websites and online products and services have their own separate privacy policies.

Collection and Use of Information

To conduct business and deliver products and services, Pearson collects and uses personal information in several ways in connection with this site, including:

Questions and Inquiries

For inquiries and questions, we collect the inquiry or question, together with name, contact details (email address, phone number and mailing address) and any other additional information voluntarily submitted to us through a Contact Us form or an email. We use this information to address the inquiry and respond to the question.

Online Store

For orders and purchases placed through our online store on this site, we collect order details, name, institution name and address (if applicable), email address, phone number, shipping and billing addresses, credit/debit card information, shipping options and any instructions. We use this information to complete transactions, fulfill orders, communicate with individuals placing orders or visiting the online store, and for related purposes.


Pearson may offer opportunities to provide feedback or participate in surveys, including surveys evaluating Pearson products, services or sites. Participation is voluntary. Pearson collects information requested in the survey questions and uses the information to evaluate, support, maintain and improve products, services or sites, develop new products and services, conduct educational research and for other purposes specified in the survey.

Contests and Drawings

Occasionally, we may sponsor a contest or drawing. Participation is optional. Pearson collects name, contact information and other information specified on the entry form for the contest or drawing to conduct the contest or drawing. Pearson may collect additional personal information from the winners of a contest or drawing in order to award the prize and for tax reporting purposes, as required by law.


If you have elected to receive email newsletters or promotional mailings and special offers but want to unsubscribe, simply email information@informit.com.

Service Announcements

On rare occasions it is necessary to send out a strictly service related announcement. For instance, if our service is temporarily suspended for maintenance we might send users an email. Generally, users may not opt-out of these communications, though they can deactivate their account information. However, these communications are not promotional in nature.

Customer Service

We communicate with users on a regular basis to provide requested services and in regard to issues relating to their account we reply via email or phone in accordance with the users' wishes when a user submits their information through our Contact Us form.

Other Collection and Use of Information

Application and System Logs

Pearson automatically collects log data to help ensure the delivery, availability and security of this site. Log data may include technical information about how a user or visitor connected to this site, such as browser type, type of computer/device, operating system, internet service provider and IP address. We use this information for support purposes and to monitor the health of the site, identify problems, improve service, detect unauthorized access and fraudulent activity, prevent and respond to security incidents and appropriately scale computing resources.

Web Analytics

Pearson may use third party web trend analytical services, including Google Analytics, to collect visitor information, such as IP addresses, browser types, referring pages, pages visited and time spent on a particular site. While these analytical services collect and report information on an anonymous basis, they may use cookies to gather web trend information. The information gathered may enable Pearson (but not the third party web trend services) to link information with application and system log data. Pearson uses this information for system administration and to identify problems, improve service, detect unauthorized access and fraudulent activity, prevent and respond to security incidents, appropriately scale computing resources and otherwise support and deliver this site and its services.

Cookies and Related Technologies

This site uses cookies and similar technologies to personalize content, measure traffic patterns, control security, track use and access of information on this site, and provide interest-based messages and advertising. Users can manage and block the use of cookies through their browser. Disabling or blocking certain cookies may limit the functionality of this site.

Do Not Track

This site currently does not respond to Do Not Track signals.


Pearson uses appropriate physical, administrative and technical security measures to protect personal information from unauthorized access, use and disclosure.


This site is not directed to children under the age of 13.


Pearson may send or direct marketing communications to users, provided that

  • Pearson will not use personal information collected or processed as a K-12 school service provider for the purpose of directed or targeted advertising.
  • Such marketing is consistent with applicable law and Pearson's legal obligations.
  • Pearson will not knowingly direct or send marketing communications to an individual who has expressed a preference not to receive marketing.
  • Where required by applicable law, express or implied consent to marketing exists and has not been withdrawn.

Pearson may provide personal information to a third party service provider on a restricted basis to provide marketing solely on behalf of Pearson or an affiliate or customer for whom Pearson is a service provider. Marketing preferences may be changed at any time.

Correcting/Updating Personal Information

If a user's personally identifiable information changes (such as your postal address or email address), we provide a way to correct or update that user's personal data provided to us. This can be done on the Account page. If a user no longer desires our service and desires to delete his or her account, please contact us at customer-service@informit.com and we will process the deletion of a user's account.


Users can always make an informed choice as to whether they should proceed with certain services offered by InformIT. If you choose to remove yourself from our mailing list(s) simply visit the following page and uncheck any communication you no longer want to receive: www.informit.com/u.aspx.

Sale of Personal Information

Pearson does not rent or sell personal information in exchange for any payment of money.

While Pearson does not sell personal information, as defined in Nevada law, Nevada residents may email a request for no sale of their personal information to NevadaDesignatedRequest@pearson.com.

Supplemental Privacy Statement for California Residents

California residents should read our Supplemental privacy statement for California residents in conjunction with this Privacy Notice. The Supplemental privacy statement for California residents explains Pearson's commitment to comply with California law and applies to personal information of California residents collected in connection with this site and the Services.

Sharing and Disclosure

Pearson may disclose personal information, as follows:

  • As required by law.
  • With the consent of the individual (or their parent, if the individual is a minor)
  • In response to a subpoena, court order or legal process, to the extent permitted or required by law
  • To protect the security and safety of individuals, data, assets and systems, consistent with applicable law
  • In connection the sale, joint venture or other transfer of some or all of its company or assets, subject to the provisions of this Privacy Notice
  • To investigate or address actual or suspected fraud or other illegal activities
  • To exercise its legal rights, including enforcement of the Terms of Use for this site or another contract
  • To affiliated Pearson companies and other companies and organizations who perform work for Pearson and are obligated to protect the privacy of personal information consistent with this Privacy Notice
  • To a school, organization, company or government agency, where Pearson collects or processes the personal information in a school setting or on behalf of such organization, company or government agency.


This web site contains links to other sites. Please be aware that we are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of each and every web site that collects Personal Information. This privacy statement applies solely to information collected by this web site.

Requests and Contact

Please contact us about this Privacy Notice or if you have any requests or questions relating to the privacy of your personal information.

Changes to this Privacy Notice

We may revise this Privacy Notice through an updated posting. We will identify the effective date of the revision in the posting. Often, updates are made to provide greater clarity or to comply with changes in regulatory requirements. If the updates involve material changes to the collection, protection, use or disclosure of Personal Information, Pearson will provide notice of the change through a conspicuous notice on this site or other appropriate way. Continued use of the site after the effective date of a posted revision evidences acceptance. Please contact us if you have questions or concerns about the Privacy Notice or any objection to any revisions.

Last Update: November 17, 2020